{
  "abstract": "Diabetes mellitus (DM) and chronic kidney disease (CKD) frequently coexist and together create a ‘triple threat’ with dyslipidaemia, enhancing the risk for cardiovascular morbidity and mortality. Diabetic kidney disease (DKD) leads to altered lipid metabolism through insulin resistance, inflammation and oxidative stress resulting in an atherogenic lipid profile that accelerates atherosclerosis and vascular dysfunction. While statins remain the cornerstone of lipid‐lowering therapy, their cardiovascular benefits decline in advanced CKD. Combination therapy with ezetimibe and newer agents, including PCSK9 inhibitors and bempedoic acid, has shown further cardiovascular risk reduction in CKD. Emerging therapies targeting alternative pathways may address residual lipid abnormalities not corrected by traditional treatments but require longer‐term outcome data in people with DM and CKD. As the prevalence of both conditions rises, applying multifaceted lipid‐lowering strategies may yield the greatest reduction in cardiovascular events and improve survival among this vulnerable population.",
  "abstract_shown": true,
  "affiliations": [
    "Division of Endocrinology, Diabetes and Metabolism Virginia Commonwealth University Richmond Virginia USA",
    "Division of Endocrinology, Diabetes and Metabolism Richmond VAMC Richmond Virginia USA",
    "Department of Endocrinology Joslin Diabetes Center, Beth‐Israel Deaconess Medical Center, Harvard Medical School Boston Massachusetts USA"
  ],
  "article_type": "review article",
  "arxiv": null,
  "author_total": 4,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Ann S. Forrest",
      "orcid": "0009-0002-6571-8032"
    },
    {
      "affs": [
        0
      ],
      "name": "Priyanka Majety"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Stéphanie B. Mayer"
    },
    {
      "affs": [
        2
      ],
      "name": "Om P. Ganda",
      "orcid": "0000-0002-4779-9273"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/f9v6hj7c5zce9.bib",
  "cited_by": 0,
  "doi": "10.1111/dom.71180",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13731010/",
  "id": "f9v6hj7c5zce9",
  "issns": [
    "1462-8902",
    "1463-1326"
  ],
  "landing_url": "https://doi.org/10.1111/dom.71180",
  "language": "en",
  "licence": "CC-BY-NC-ND-4.0",
  "licence_label": "CC BY-NC-ND 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Review Article"
    ],
    [
      "openalex",
      "2705|Lipoproteins and Cardiovascular Health"
    ]
  ],
  "openalex": "W7204176858",
  "pdf_url": "https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.71180",
  "pmcid": "PMC13731010",
  "pmid": "42638217",
  "published": "2026-08-24",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/f9v6hj7c5zce9.ris",
  "sources": [
    {
      "first_seen": "2026-11-08T12:21:17Z",
      "native_id": "PMC13731010",
      "source": "pmc",
      "url": "https://doi.org/10.1111/dom.71180"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2705|Lipoproteins and Cardiovascular Health",
      "subfield": "cardiovascular"
    }
  ],
  "title": "Dyslipidaemia, Chronic Kidney Disease and Diabetes Mellitus: A Triple Threat to Cardiovascular Health",
  "title_text": "Dyslipidaemia, Chronic Kidney Disease and Diabetes Mellitus: A Triple Threat to Cardiovascular Health",
  "type": "peer-reviewed",
  "updated_at": "2026-11-08T12:21:17Z",
  "url": "https://research.draconitic.com/paper/f9v6hj7c5zce9",
  "venue": "Diabetes, Obesity & Metabolism",
  "versions": []
}